Acknowledg Committee a 1.1 Ms.Pi 1.2 Mr.Su Effective fro Approved t replace the 2.1 Ms. Comm 2.2 Mr. S tion on the Directors, a nd Manager Exchange o orm for Re Audit Comm nformation M amended No ectors’ meet
Discussion and Analysis For the year 2017 To The President of the Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Results for the year 2017 For the year ended 31 December
10th May, 2018 Subject: Management Discussion and Analysis (MD&A) of the financial as at and for three months’ period ending 31st March, 2018 Attention: President The Stock Exchange of Thailand P.C.S
and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the audited separated and consolidated financial statements for the year ended
Registration No. : 0107535000371 No. L001/2019 20th February 2019 Subject : The explanation of operating results for the year 2018 Attention : The President The Stock Exchange of Thailand Dear Sir, For the year
. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public
-TRANSLATION- 25 February 2020 Subject : Management Discussion and Analysis for 2019 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in
the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company
-TRANSLATION- 11 August 2017 Subject : Management Discussion and Analysis for Q2/2017 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in